Atea Pharmaceuticals, Inc.AVIRNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-135.50M
↓ 513% below average
Average (6y)
$-22.12M
Historical baseline
Range
High:$296.71M
Low:$-135.50M
CAGR
+60.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-135.50M | -58.7% |
| 2023 | $-85.39M | +30.5% |
| 2022 | $-122.92M | -41.3% |
| 2021 | $-87.01M | -129.3% |
| 2020 | $296.71M | +2415.1% |
| 2019 | $-12.82M | -61.8% |
| 2018 | $-7.92M | - |